Skip to main content

Table 2 Clinicopathological features of the patients in cohort 2 (N = 106)

From: Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?

Clinicopathological features n LC P value LWR P value
Decreased Increased   Decreased Increased  
Age (M (P 25 ~ P 75)) 106 64(56-69) 62(53-72) 0.3708 64(56-72) 62(53-70) 0.2784
Gender     0.0517    0.9756
 Male 56(52.83%) 23(43.40%) 33(62.26%)   36(52.94%) 20(52.63%)  
 Female 50(47.17%) 30(56.60%) 20(37.74%)   32(47.06%) 18(47.37%)  
Tumor stage     0.0382    0.0010
 III 13(12.26%) 3(5.66%) 10(18.87%)   3(4.41%) 10(26.32%)  
 IV 93(87.74%) 50(94.34%) 43(81.13%)   65(95.59%) 28(73.68%)  
Primary tumor site     0.6794    0.3937
 Gastrointestinal tumors 60(56.60%) 33(62.26%) 27(50.94%)   41(60.29%) 19(50.00%)  
 Thoracic ancer 14(13.21%) 6(11.32%) 8(15.09%)   9(13.24%) 5(13.16%)  
 Urogenital neoplasms 23(21.70%) 9(16.98%) 14(26.42%)   11(16.18%) 12(31.58%)  
 Head and neck neoplasm 6(5.66%) 3(5.66%) 3(5.66%)   5(7.35%) 1(2.63%)  
 Other tumors 3(2.83%) 2(3.77%) 1(1.89%)   2(2.94%) 1(2.63%)  
Family history     0.2943    0.4234
 No 73(68.87%) 34(64.15%) 39(73.58%)   45(66.18%) 28(73.68%)  
 Yes 33(31.13%) 19(35.85%) 14(26.42%)   23(33.82%) 10(26.32%)  
Smoking history     0.0905    0.8157
 No 74(69.81%) 41(77.36%) 33(62.26%)   48(70.59%) 26(68.42%)  
 Yes 32(30.19%) 12(22.64%) 20(37.74%)   20(29.41%) 12(31.58%)  
ECOG     0.1093    0.6462
  < 3 81(76.42%) 37(69.81%) 44(83.02%)   51(75.00%) 30(78.95%)  
  > =3 25(23.58%) 16(30.19%) 9(16.98%)   17(25.00%) 8(21.05%)  
Concomitant disease     0.5529    0.8093
 No 63(59.43%) 33(62.26%) 30(56.60%)   41(60.29%) 22(57.89%)  
 Yes 43(40.57%) 20(37.74%) 23(43.40%)   27(39.71%) 16(42.11%)  
Nutrient status     0.9360    0.4560
 Normal 42(40.00%) 21(40.38%) 21(39.62%)   25(37.31%) 17(44.74%)  
 Abnormal 63(60.00%) 31(59.62%) 32(60.38%)   42(62.69%) 21(55.26%)  
 Unknown 1 1 -   1 -  
  1. SD standard deviation, LC lymphocyte count, LWR lymphocyte to white blood cell ratio